CD9 and Glanzmann thrombasthenia 1: MC revealed significantly elevated CD9 surface expression on platelets from our GT patient cohort following agonist stimulation (0.5 μM ADP and 20 μM TRAP) compared to healthy donor platelets (Fig. 5B).